Drugs by condition
Drugs approved for psoriatic arthritis
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
58
Still marketed, NDA or BLA
Drug classes
11
Novel drugs
19
New molecular entities and new biologics
In development
12
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for psoriatic arthritis.
All approved drugs for psoriatic arthritis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 151 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Tumor Necrosis Factor Blocker (12)
- Simponi Golimumab · Centocor Ortho Biotech INC · 2009
- Cimzia Certolizumab Pegol · Ucb INC · 2008
- Enbrel Etanercept · Immunex · 1998
- Remicade Infliximab · Centocor INC · 1998
- Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
- Avsola Infliximab-Axxq · Amgen INC · 2019
- Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
- Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
- Renflexis Infliximab-Abda · Samsung Bioepis CO LTD · 2017
- Amjevita Adalimumab-Atto · Amgen INC · 2016
- Inflectra Infliximab-Dyyb · Celltrion INC · 2016
- Simponi Aria Golimumab · Janssen Biotech · 2013
Interleukin-12 Antagonist (9)
- Stelara Ustekinumab · Centocor Ortho Biotech INC · 2009
- Starjemza Ustekinumab-Hmny · Bio-Thera Solutions LTD · 2025
- Otulfi Ustekinumab-Aauz · Fresenius Kabi USA · 2025
- Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2025
- Steqeyma Ustekinumab-Stba · Celltrion, Inc. · 2024
- Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2024
- Wezlana Ustekinumab-Auub · Amgen INC · 2023
- Wezlana Ustekinumab-Auub · Amgen INC · 2023
- Stelara Ustekinumab · Janssen Biotech · 2016
Interleukin-23 Antagonist (4)
Interleukin-17A Antagonist (3)
Corticosteroid (3)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Janus Kinase Inhibitor (2)
Phosphodiesterase 4 Inhibitor (2)
Adrenocorticotropic Hormone (2)
- Purified Cortrophin Gel Corticotropin · Ani Pharms · 1954
- Acthar Gel Corticotropin · Mallinckrodt Ireland · 1952
Tyrosine Kinase 2 Inhibitor (1)
- Sotyktu Deucravacitinib · Bristol · 2022
Selective T Cell Costimulation Modulator (1)
- Orencia Abatacept · Bristol Myers Squibb · 2005
Class not listed in FDA's data (19)
- Bimzelx Bimekizumab-Bkzx · Ucb INC · 2023
- Xeljanz Tofacitinib Citrate · Pf Prism Cv · 2012
- Humira Adalimumab · Abbvie INC · 2002
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Imuldosa Ustekinumab-Srlf · Accord Biopharma Inc. · 2024
- Selarsdi Ustekinumab-Aekn · Alvotech USA INC · 2024
- Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
- Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
- Yuflyma Adalimumab-Aaty · Celltrion · 2023
- Xeljanz Tofacitinib Citrate · Pfizer · 2020
- Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
- Abrilada Adalimumab-Afzb · Pfizer INC · 2019
- Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017
- Xeljanz Xr Tofacitinib Citrate · Pfizer · 2016
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for psoriatic arthritis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ZasocitinibTAK- 279, NDI-034858Phase 317 trials
Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- TQH3906Phase 34 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Psoriasis, Systemic Lupus Erythematosus, Psoriatic Arthritis
- SHR-1314Phase 33 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Active Non-radiographic Axial Spondyloarthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis
- PicankibartPhase 32 trials
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis
- SHR0302Phase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Non-segmental Vitiligo, Psoriatic Arthritis
- TILDPhase 32 trials
Sun Pharmaceutical Industries Limited · Active Psoriatic Arthritis
- DDY391Phase 23 trials
Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- SPY002-072SPY072Phase 22 trials
Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- ABBV-547Phase 21 trial
AbbVie · Psoriatic Arthritis
More on psoriatic arthritis: recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.